|1.||Stegemann, M R: 5 articles (06/2008 - 07/2006)|
|2.||Sherington, J: 5 articles (06/2008 - 07/2006)|
|3.||Passmore, C A: 4 articles (06/2008 - 07/2006)|
|4.||Boucher, Joseph F: 3 articles (05/2011 - 08/2008)|
|5.||Skaanild, M T: 2 articles (10/2011 - 12/2009)|
|6.||Thuesen, L R: 2 articles (10/2011 - 12/2009)|
|7.||Bertelsen, M F: 2 articles (10/2011 - 12/2009)|
|8.||Lindeman, Cindy J: 2 articles (01/2009 - 08/2008)|
|9.||Stegemann, Michael R: 2 articles (01/2009 - 08/2008)|
|10.||Chesebrough, Robert: 2 articles (01/2009 - 08/2008)|
|1.||Urinary Tract Infections (Urinary Tract Infection)
06/01/2008 - "Cefovecin was demonstrated to be an effective and safe treatment for urinary tract infections."
03/01/2007 - "Cefovecin was shown to be an effective and safe treatment for urinary tract infections."
01/01/2015 - "The aim of this study was to determine the bacterial species recovered from 61 cats with lower urinary tract infection (LUTI), and their susceptibility to cefovecin in vitro. "
01/01/2015 - "Bacterial species isolated from cats with lower urinary tract infection and their susceptibilities to cefovecin."
06/01/2008 - "To determine the efficacy and safety of cefovecin (Convenia); Pfizer Animal Health) in the treatment of urinary tract infections in cats. "
02/01/2013 - "pseudintermedius, as well as the in vivo efficacy of cefovecin therapy in dogs with superficial pyoderma caused by S. "
07/01/2007 - "Clinical efficacy and safety of cefovecin in the treatment of canine pyoderma and wound infections."
08/01/2012 - "A good level of evidence was identified supporting the high efficacy of subcutaneously injected cefovecin in superficial pyoderma and for oral amoxicillin-clavulanic acid in deep pyoderma. "
02/01/2013 - "To determine the usefulness of an in vitro cefovecin disk-diffusion test in predicting the presence of the mecA gene in Staphylococcus pseudintermedius, as well as the in vivo efficacy of cefovecin therapy in dogs with superficial pyoderma. "
02/01/2013 - "Usefulness of cefovecin disk-diffusion test for predicting mecA gene-containing strains of Staphylococcus pseudintermedius and clinical efficacy of cefovecin in dogs with superficial pyoderma."
01/01/2015 - "It is the first study on in vitro activity of cefovecin against bacterial isolates from cats with lower urinary infections in Istanbul, Turkey."
08/01/2015 - "In the absence of additional microbial susceptibility data for alpaca pathogens, the current cefovecin dosage regimen prescribed for dogs (8 mg/kg SC every 14 days) may need to be optimized for the treatment of infections in this species."
01/01/2015 - "Cefovecin is not efficacious for treatment of RGM infections."
10/01/2013 - "Cefovecin is an extended-spectrum long-acting third generation cephalosporin used to treat canine infections. "
02/01/2013 - "Cefovecin has been widely used to treat skin infections in dogs. "
|4.||Respiratory Tract Diseases (Respiratory Tract Disease)
07/15/2012 - "To compare efficacy of amoxicillin-clavulanic acid, cefovecin, and doxycycline in shelter-housed cats with clinical signs of upper respiratory tract disease (URTD). "
07/15/2012 - "Comparison of the efficacy of amoxicillin-clavulanic acid, cefovecin, and doxycycline in the treatment of upper respiratory tract disease in cats housed in an animal shelter."
|5.||Periodontal Diseases (Periodontal Disease)
|1.||Amoxicillin-Potassium Clavulanate Combination (Co-amoxiclav)